Guidelines for clinical research in developing countries

被引:1
|
作者
Way, Muriel
Simon, Francois
Bompart, Francois
d'Alessandro, Umberto
Belorgey, Chantal
Bilbault, Pascal
Bompart, Francois
Champey, Yves
Deloron, Philippe
Demarez, Jean Paul
Dessein, Alain
Funck-Bruntano, Christian
Gersberg, Marta
Hirsch, Francois
Kande, Victor
Kapere, Solomon
Lassale, Catherine
Lemerle, Jean
Pilorge, Fabrice
Riveau, Gilles
Simon, Francois
Ter-Minassian, Daniel
机构
[1] Inst Pasteur, Unite Epidemiol Malad Emergentes, F-75015 Paris, France
[2] CHU St Loiuis, Microbiol Serv, Paris, France
[3] Sanofi Aventis, Direct Acces Medicament, Paris, France
来源
THERAPIE | 2007年 / 62卷 / 03期
关键词
clinical research; ethics; developing countries;
D O I
10.2515/therapie:2007045
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
On the basis of a review of current clinical research conditions in developing countries, guidelines have been formulated to ensure scientific validity as well as adherence to universal ethical principles. The main recommendation is that projects should be reviewed by two Institutional Review Boards, one in the country where the Study Sponsor is based, and another in the country where the study is being carried out. In addition, an independent Data Safety Monitoring Board should be set up and systems established to ensure the effective reporting of Serious Adverse Events and to specify the Sponsor's obligations after the end of the Study.
引用
收藏
页码:223 / 227
页数:5
相关论文
共 50 条